Recombinant Cynomolgus Monkey CTLA-4 Fc Chimera, CF
| Name | Recombinant Cynomolgus Monkey CTLA-4 Fc Chimera, CF |
|---|---|
| Supplier | R&D Systems |
| Catalog | 9336-CT |
| Category | Protein |
| Prices | $369.00, $1,200.00 |
| Sizes | 200 µg, 1 mg |
| Species Reactivities | Monkey |
| Nature | Recombinant |
| Source | Human embryonic kidney cell, HEK293-derived Cynomolgus Monkey CTLA-4 (Ala37-Asp161) Accession # XP_005574071 IEGRMD Human IgG 1 (Pro100-Lys330) N-terminus C-terminus |
| Purity | >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining. |
| Bioactivity | Measured by its binding ability in a functional ELISA. When Recombinant Cynomolgus Monkey CTLA‑4 Fc Chimera is coated at 0.5 µg/mL, 100 μL/well, Recombinant Human B7‑1/CD80 Fc Chimera (Catalog # 140-B1 ) binds with an ED 50 of 5-30 ng/mL. |
| Endotoxin | <0.10 EU per 1 μg of the protein by the LAL method. |
| SwissProt/Accession | XP_005574071 |
| Gene | CTLA4 |
| Sequence | Ala37 |
| Supplier Page | Shop |
Product images
When Recombinant Cynomolgus Monkey CTLA‑4 FcChimera (Catalog # 9336-CT) is coated at 0.5 µg/mL,100 μL/well, Recombinant Human B7‑1/CD80 Fc Chimera (Catalog # 140-B1 ) binds with anED 50 of 5-30 ng/mL.